N. Nakakuki

发表

Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma

N. Enomoto, M. Sakamoto, K. Moriishi, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

N. Enomoto, M. Kurosaki, N. Izumi, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Usefulness of Cell‐Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy

N. Enomoto, K. Yamauchi, S. Maekawa, 2021, Hepatology communications.

N. Enomoto, M. Matsuda, K. Moriishi, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Irregular vascular pattern by contrast‐enhanced ultrasonography and high serum Lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early‐stage hepatocellular carcinoma

N. Enomoto, M. Kurosaki, N. Izumi, 2016, Cancer medicine.

Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy

N. Enomoto, M. Kurosaki, N. Izumi, 2015, PloS one.

Wisteria floribunda agglutinin positive human Mac‐2‐binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

M. Kurosaki, N. Izumi, A. Kuno, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing

N. Enomoto, D. Ichikawa, T. Kondo, 2021, International journal of molecular sciences.

Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites

M. Kurosaki, N. Izumi, S. Sasaki, 2016, Journal of Gastroenterology.

Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma

M. Kurosaki, N. Izumi, M. Sakamoto, 2016, PloS one.

L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis.

M. Kurosaki, N. Izumi, H. Nakanishi, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens

M. Kurosaki, N. Izumi, Y. Asahina, 2015, PloS one.

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers

N. Enomoto, M. Sakamoto, K. Moriishi, 2019, PloS one.

Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.

Kunihiko Hashimoto, I. Katoh, H. Hirai, 2011, Neoplasia.

Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric Neoplasms

M. Kurosaki, N. Izumi, H. Nakanishi, 2016, PloS one.

Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma

N. Enomoto, S. Maekawa, M. Fukasawa, 2021, Reports.

Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C

N. Enomoto, M. Sakamoto, M. Nakagawa, 2018, Journal of Gastroenterology.

Deep sequencing analysis of serum hepatitis B virus‐RNA during nucleot(s)ide analogue therapy

N. Enomoto, K. Moriishi, S. Maekawa, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma

N. Enomoto, S. Maekawa, M. Fukasawa, 2022, Oncology.

Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration

N. Enomoto, H. Onishi, S. Maekawa, 2022, JGH Open.

HBV patients with low HBsAg and high HBcrAg titers have a high risk of HBV‐related HCC

N. Enomoto, M. Sakamoto, K. Moriishi, 2018 .

Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography

M. Yin, U. Motosugi, N. Enomoto, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment

M. Kurosaki, N. Izumi, H. Nakanishi, 2016, Liver Cancer.

Analysis of direct‐acting antiviral‐resistant hepatitis C virus haplotype diversity by single‐molecule and long‐read sequencing

N. Enomoto, K. Yamauchi, S. Maekawa, 2022, Hepatology communications.

Effect of a combination of pemafibrate and a mild low‐carbohydrate diet on obese and non‐obese patients with metabolic‐associated fatty liver disease

H. Morisaka, N. Enomoto, H. Onishi, 2023, Journal of gastroenterology and hepatology.

Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma

N. Enomoto, S. Maekawa, Mitsuaki Sato, 2023, Oncology.